Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases.

Amy FullerJennie HancoxHywel C WilliamsTim CardMaarten W TaalGuruprasad P AithalChristopher P FoxChristian D MallenJames R MaxwellSarah BinghamKavita VedharaAbhishek Abhishek

Published in: Rheumatology (Oxford, England) (2024)

A risk-stratified approach to monitoring was acceptable to patients and HCPs. Guideline groups should consider these findings when recommending blood-test monitoring intervals.

Keyphrases

end stage renal disease
newly diagnosed
healthcare
public health
chronic kidney disease
prognostic factors
peritoneal dialysis
case report
signaling pathway
oxidative stress
patient reported outcomes
social media
human health